Bristol-Myers Squibb Co
NYSE:BMY
Bristol-Myers Squibb Co
NYSE:BMY
Price:
43.99 USD
0.66%
Market Closed
Updated:
May 4, 2024
Balance Sheet
Balance Sheet Decomposition
Bristol-Myers Squibb Co
Bristol-Myers Squibb Co
| Current Assets | 28.7B |
| Cash & Short-Term Investments | 9.7B |
| Receivables | 14.1B |
| Other Current Assets | 4.9B |
| Non-Current Assets | 70.4B |
| Long-Term Investments | 2.2B |
| PP&E | 8.2B |
| Intangibles | 54.5B |
| Other Non-Current Assets | 5.5B |
| Current Liabilities | 25.8B |
| Accounts Payable | 3.5B |
| Accrued Liabilities | 9.9B |
| Short-Term Debt | 3.3B |
| Other Current Liabilities | 9B |
| Non-Current Liabilities | 56.7B |
| Long-Term Debt | 49.5B |
| Other Non-Current Liabilities | 7.2B |
Balance Sheet
Bristol-Myers Squibb Co
Bristol-Myers Squibb Co
Currency: USD
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
5 571
|
2 385
|
4 237
|
5 421
|
6 911
|
12 346
|
14 546
|
13 979
|
9 123
|
11 464
|
|
| Cash Equivalents |
5 571
|
2 385
|
4 237
|
5 421
|
6 911
|
12 346
|
14 546
|
13 979
|
9 123
|
11 464
|
|
| Short-Term Investments |
1 864
|
1 885
|
2 113
|
1 391
|
1 973
|
3 047
|
1 285
|
2 987
|
130
|
816
|
|
| Total Receivables |
3 212
|
4 117
|
4 916
|
5 609
|
5 747
|
7 685
|
8 501
|
9 369
|
9 886
|
15 264
|
|
| Accounts Receivables |
2 100
|
2 948
|
3 774
|
4 347
|
4 636
|
6 476
|
7 219
|
7 979
|
8 151
|
9 298
|
|
| Other Receivables |
1 112
|
1 169
|
1 142
|
1 262
|
1 111
|
1 209
|
1 282
|
1 390
|
1 735
|
5 966
|
|
| Inventory |
1 560
|
1 221
|
1 241
|
1 166
|
1 195
|
4 293
|
2 074
|
2 095
|
2 339
|
2 662
|
|
| Other Current Assets |
2 401
|
807
|
1 197
|
1 267
|
1 334
|
1 983
|
3 786
|
4 832
|
5 795
|
1 564
|
|
| Total Current Assets |
14 608
|
10 415
|
13 704
|
14 854
|
17 160
|
29 354
|
30 192
|
33 262
|
27 273
|
31 770
|
|
| PP&E Net |
4 417
|
4 412
|
4 980
|
5 001
|
5 027
|
6 956
|
6 745
|
6 968
|
7 475
|
8 036
|
|
| PP&E Gross |
4 417
|
4 412
|
4 980
|
5 001
|
5 027
|
6 956
|
6 745
|
6 968
|
7 475
|
8 036
|
|
| Accumulated Depreciation |
4 649
|
4 219
|
4 193
|
3 986
|
3 818
|
3 955
|
3 585
|
4 033
|
4 164
|
4 803
|
|
| Intangible Assets |
1 753
|
1 419
|
1 385
|
1 210
|
1 091
|
63 969
|
53 243
|
42 527
|
35 859
|
27 072
|
|
| Goodwill |
7 027
|
6 881
|
6 875
|
6 863
|
6 538
|
22 488
|
20 547
|
20 502
|
21 149
|
21 169
|
|
| Long-Term Investments |
4 408
|
4 660
|
2 719
|
2 480
|
1 775
|
4 601
|
4 509
|
2 713
|
2 187
|
2 063
|
|
| Other Long-Term Assets |
1 536
|
3 961
|
4 044
|
3 143
|
3 395
|
2 576
|
3 245
|
3 342
|
2 877
|
5 049
|
|
| Other Assets |
7 027
|
6 881
|
6 875
|
6 863
|
6 538
|
22 488
|
20 547
|
20 502
|
21 149
|
21 169
|
|
| Total Assets |
33 749
N/A
|
31 748
-6%
|
33 707
+6%
|
33 551
0%
|
34 986
+4%
|
129 944
+271%
|
118 481
-9%
|
109 314
-8%
|
96 820
-11%
|
95 159
-2%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
2 487
|
1 565
|
1 664
|
2 248
|
1 892
|
2 445
|
2 713
|
2 949
|
3 040
|
3 259
|
|
| Accrued Liabilities |
3 310
|
4 073
|
4 587
|
5 313
|
5 687
|
8 100
|
9 582
|
10 104
|
10 374
|
11 204
|
|
| Short-Term Debt |
0
|
0
|
243
|
987
|
454
|
583
|
340
|
184
|
367
|
246
|
|
| Current Portion of Long-Term Debt |
590
|
139
|
749
|
0
|
1 249
|
2 763
|
2 000
|
4 764
|
3 897
|
2 873
|
|
| Other Current Liabilities |
2 074
|
2 240
|
1 598
|
1 015
|
1 372
|
4 413
|
4 445
|
3 867
|
4 212
|
4 680
|
|
| Total Current Liabilities |
8 461
|
8 017
|
8 841
|
9 563
|
10 654
|
18 304
|
19 080
|
21 868
|
21 890
|
22 262
|
|
| Long-Term Debt |
7 242
|
6 550
|
5 716
|
6 975
|
5 646
|
43 387
|
48 336
|
39 605
|
35 056
|
36 653
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
6 454
|
5 407
|
4 501
|
2 166
|
338
|
|
| Minority Interest |
131
|
158
|
170
|
106
|
96
|
100
|
60
|
60
|
57
|
55
|
|
| Other Liabilities |
3 063
|
2 757
|
2 803
|
5 166
|
4 559
|
10 101
|
7 776
|
7 334
|
6 590
|
6 421
|
|
| Total Liabilities |
18 897
N/A
|
17 482
-7%
|
17 530
+0%
|
21 810
+24%
|
20 955
-4%
|
78 346
+274%
|
80 659
+3%
|
73 368
-9%
|
65 759
-10%
|
65 729
0%
|
|
| Equity | |||||||||||
| Common Stock |
221
|
221
|
221
|
221
|
221
|
292
|
292
|
292
|
292
|
292
|
|
| Retained Earnings |
32 541
|
31 613
|
33 513
|
31 160
|
34 065
|
34 474
|
21 281
|
23 820
|
25 503
|
28 766
|
|
| Additional Paid In Capital |
1 507
|
1 459
|
1 725
|
1 898
|
2 081
|
43 709
|
44 325
|
44 361
|
45 165
|
45 684
|
|
| Unrealized Security Profit/Loss |
31
|
23
|
7
|
32
|
30
|
6
|
11
|
2
|
0
|
2
|
|
| Treasury Stock |
16 992
|
16 559
|
16 779
|
19 249
|
19 574
|
25 357
|
26 237
|
31 259
|
38 618
|
43 766
|
|
| Other Equity |
2 456
|
2 445
|
2 496
|
2 321
|
2 732
|
1 526
|
1 850
|
1 270
|
1 281
|
1 548
|
|
| Total Equity |
14 852
N/A
|
14 266
-4%
|
16 177
+13%
|
11 741
-27%
|
14 031
+20%
|
51 598
+268%
|
37 822
-27%
|
35 946
-5%
|
31 061
-14%
|
29 430
-5%
|
|
| Total Liabilities & Equity |
33 749
N/A
|
31 748
-6%
|
33 707
+6%
|
33 551
0%
|
34 986
+4%
|
129 944
+271%
|
118 481
-9%
|
109 314
-8%
|
96 820
-11%
|
95 159
-2%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
1 653
|
1 661
|
1 664
|
1 625
|
1 624
|
2 228
|
2 221
|
2 153
|
2 075
|
2 021
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
